Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4CG8

Human choline kinase a1 in complex with compound 14

Summary for 4CG8
Entry DOI10.2210/pdb4cg8/pdb
Related4CG9 4CGA
DescriptorCHOLINE KINASE ALPHA, 4-[(4-chlorophenyl)(methyl)amino]-1-{4-[4-(4-{[4-(dimethylamino)pyridinium-1-yl]methyl}phenyl)butyl]benzyl}pyridinium, 1-benzyl-4-(dimethylamino)pyridinium, ... (4 entities in total)
Functional Keywordstransferase, drug target, cancer
Biological sourceHOMO SAPIENS (HUMAN)
Cellular locationCytoplasm: P35790
Total number of polymer chains1
Total formula weight45744.96
Authors
Rubio-Ruiz, B.,Figuerola-Conchas, A.,Entrena-Guadix, A.,Hurtado-Guerrero, R.,Conejo-Garcia, A. (deposition date: 2013-11-21, release date: 2014-01-15, Last modification date: 2023-12-20)
Primary citationRubio-Ruiz, B.,Figuerola-Conchas, A.,Ramos-Torrecillas, J.,Capitan-Canadas, F.,Rios-Marco, P.,Carrasco, M.P.,Gallo, M.A.,Espinosa, A.,Marco, C.,Concepcion, C.,Entrena-Guadix, A.,Hurtado-Guerrero, R.,Conejo-Garcia, A.
Discovery of a New Binding Site on Human Choline Kinase A1: Design, Synthesis, Crystallographic Studies and Biological Evaluation of Asymmetrical Bispyridinium Derivatives
J.Med.Chem., 57:507-, 2014
Cited by
PubMed Abstract: Human choline kinase α (CKα) is a validated drug target for the treatment of cancer. In recent years, a large number of CK inhibitors have been synthesized, and one of them is currently being evaluated in Phase I clinical trials as a treatment for solid tumors. Here we have evaluated a new series of asymmetrical biscationic CK inhibitors by means of enzymatic, crystallographic, and antitumor studies. We demonstrate that one of these structures adopts a completely new binding mode not observed before inducing the aperture of an adjacent binding site. This compound shows antiproliferative and apoptotic effects on cancer cells through activation of caspase-3. Therefore, this study not only provides fruitful insights into the design of more efficient compounds that may target different regions in CKα1 but also explains how these compounds induce apoptosis in cancer cells.
PubMed: 24387243
DOI: 10.1021/JM401665X
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon